First-ever Oropouche Virus Cases Reported in Europe Amid Rising Concerns
Travel warnings issued as Europe sees its first cases
Europe has reported its first-ever cases of Oropouche virus infection, marking a significant development just weeks after the tropical disease claimed its first victims in Brazil. Health authorities across the continent are now urging caution, particularly for travelers returning from regions where the virus is known to be prevalent.
Cases emerge in Spain, Italy, and Germany
Nineteen cases of Oropouche virus (OROV) disease have been confirmed in Europe, with Spain reporting 12 cases, Italy five, and Germany two. Notably, all these cases are imported, with 18 individuals having traveled to Cuba and one to Brazil. The emergence of these cases has prompted European health officials to issue travel warnings, particularly for those visiting Brazil and Cuba, where the virus is most active.
A growing threat in the Americas
Oropouche virus disease, second only to Dengue in terms of prevalence among insect-borne viral diseases in South America, has seen a significant surge this year. Countries like Brazil, Bolivia, Colombia, Peru, and Cuba have reported widespread outbreaks, with Brazil being the hardest hit. In 2024 alone, Brazil has recorded nearly 7,300 cases, a sharp increase from the 832 reported last year.
Brazilian health officials have raised alarms over the virus’s potential link to birth defects and miscarriages, noting that Oropouche can be transmitted from mother to child. The two Brazilian women who succumbed to the virus in July were in their 20s and presented severe symptoms, including fever, joint pain, headaches, and hemorrhaging, before rapidly deteriorating.
Understanding the Oropouche virus
The Oropouche virus (OROV) is a rare zoonotic disease that infects humans primarily through the bites of infected midges, gnats, and mosquitoes, with the main vector being the midge Culicoides paraensis. This insect is widespread in the Americas but notably absent in Europe, which has raised concerns about the potential for the virus to spread further.
While fatalities from OROV disease are extremely rare, the recent deaths in Brazil have heightened concern. Health experts emphasize that there have been no recorded cases of human-to-human transmission of the virus.
Symptoms and challenges in diagnosis
The symptoms of Oropouche virus infection include fever, headache, nausea, vomiting, dizziness, and rashes. The U.S. Centers for Disease Control and Prevention (CDC) also lists muscle aches, stiff joints, chills, and sensitivity to light as common symptoms. In severe cases, the virus can cause neuroinvasive diseases such as meningitis.
Symptoms typically appear four to eight days after being bitten and last three to six days, with most individuals recovering without long-term effects. However, the disease is often misidentified as dengue fever, complicating efforts to diagnose and treat affected individuals.
No treatment or vaccine available
Currently, there is no known treatment or vaccine for Oropouche viral disease, further complicating efforts to manage and contain outbreaks. The virus, named after the Oropouche River in Trinidad and Tobago, was first detected in 1955 at the Trinidad Regional Virus Laboratory.
As the Oropouche virus continues to spread, health authorities are closely monitoring the situation, particularly in Europe, where the first cases have now been reported. Travelers are advised to exercise caution and take preventive measures when visiting affected regions.
